Coronavirus

Flu cases surge in the UK hospitals while China battles human metapneumovirus

Flu Season: New data from the NHS shows rapid rise in flu cases across the UK, whilst across the world, china continues its battle against human metapneumovirus virus.

The Higher Education estate post-COVID

Mark Paget Skelin, Partner at law firm Bevan Brittan LLP, explains his predictions concerning the appearance of the Higher Education estate in a post-COVID world.

Scientists say over half of virus survivors have Long COVID

According to scientists at Penn State College of Medicine, over half of virus survivors contract Long COVID.

Report finds COVID patients with learning disabilities given blanket DNRs

The Health Committee report examines UK COVID decisions - including a chilling blanket DNR given to COVID patients with learning disabilities.

MPs say UK Test and Trace system “ultimately failed” to stop deaths

The 150-page Health and Social Committee report says the UK Government "ultimately failed" to establish a working Test and Trace system - which led to thousands of COVID deaths.

Scientists identify gene linking severe COVID and Alzheimer’s

A new study has uncovered a gene that links severe COVID and Alzheimer's, via "immune system changes" that can happen in both conditions.

Neuromodulation clears symptoms of severe, untreatable depression

Targeted neuromodulation may be a future method to help those with severe, untreatable depression - traditionally, this is used to correct misfiring brain circuits in people with epilepsy or Parkinson's.

Merck “COVID pill” sold at forty-times what it costs to make

The "COVID pill" by Merck, found to halve virus hospitalisation and death rates, will be sold in the US at $712 per treatment - while costing $17.74 to produce.

The COVID insight of Molecular and Cellular Biosciences

We reflect on the work of the Molecular and Cellular Biosciences division (MCB), especially in context of the “complex biological web” of a global pandemic.

Study finds Pfizer vaccine works at 90% efficacy for six months

The study, published in The Lancet, finds that two doses of the Pfizer vaccine are 90% efficient for six months - decreasing to 47% after that time period.

One in seven patients missed cancer surgery during lockdown

A new study reveals that one in seven patients missed their cancer surgery during lockdown, globally.

Study reveals taking regular walks changes brain structure

New research suggests that regular walks can change brain structure - a team of scientists noticed changes in the prefrontal cortex, which improved participant concentration and memory.

Mental health in light of the COVID-19 pandemic

Dr Hans Henri P. Kluge, Regional Director & Dr Natasha Azzopardi-Muscat, Director of Country Health Policies and Systems at WHO/Europe, lift the lid on mental health in light of the COVID-19 pandemic.

Convalescent plasma treatment ineffective for critically ill COVID patients

A new study finds that convalescent plasma treatment, popular at the onset of COVID, is not effective for critically ill, older COVID patients.

Study says 0.0006% chance of myocarditis as COVID vaccine side effect

According to a study with 2,392,924 participants, acute myocarditis is an extremely rare side effect of the COVID vaccine - at 0.0006% likelihood.

Scientists say microscopic blood clots cause Long COVID

A new study proposes that microscopic blood clots could be causing ongoing symptoms for some people with Long COVID.

Researchers say COVID created largest life expectancy decrease since WWII

According to Oxford University researchers, COVID created the largest life expectancy decrease since WWII - with 93.1% of countries seeing a significant decline.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders